N@N

Derma Sciences to Present at the Fourth Annual Maxim Group Growth Conference

^{Published on 2010-11-16 13:00:22 - Market Wire}
 

PRINCETON, N.J.--([ BUSINESS WIRE ])--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that the company will be participating in the Fourth Annual Maxim Group Growth Conference being held at the Grand Hyatt New York in New York City on Thursday, November 18, 2010. John E. Yetter, chief financial officer, will deliver the Companya™s corporate presentation on Thursday, November 18, at 9:30 a.m. (Eastern Time).

The presentation will be webcast live at [ http://www.wsw.com/webcast/maxim3/dsci/ ] and on the Investor Relations section of the Companya™s website at [ www.dermasciences.com ], where it will also be archived for 90 days.

About Derma Sciences, Inc.

Derma Sciences is a medical technology company focused on three segments of the wound care marketplace, traditional dressings, advanced wound care dressings and pharmaceutical wound care products. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 leg ulcer patients. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudates, and BIOGUARD® for infection prevention. Derma Sciences expects to complete the efficacy portion of its Phase II clinical study with DSC127, a novel pharmaceutical for accelerated wound healing and scar reduction, by the end of 2010.

For more information please visit [ www.dermasciences.com ].